Legend Biotech Corp. (LEGN)
19.01
+0.36
(+1.93%)
USD |
NASDAQ |
Oct 20, 16:00
18.87
-0.14
(-0.74%)
Pre-Market: 08:02
Legend Biotech Research and Development Expense (TTM) : 397.18M for June 30, 2026
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 397.18M |
| March 31, 2026 | 399.67M |
| December 31, 2025 | 415.64M |
| September 30, 2025 | 417.93M |
| June 30, 2025 | 400.16M |
| March 31, 2025 | 414.13M |
| December 31, 2024 | 413.17M |
| September 30, 2024 | 414.80M |
| June 30, 2024 | 415.13M |
| March 31, 2024 | 398.29M |
| December 31, 2023 | 382.22M |
| September 30, 2023 | 357.29M |
| June 30, 2023 | 365.95M |
| Date | Value |
|---|---|
| March 31, 2023 | 338.99M |
| December 31, 2022 | 335.65M |
| September 30, 2022 | 341.40M |
| June 30, 2022 | 309.19M |
| March 31, 2022 | 323.82M |
| December 31, 2021 | 313.21M |
| September 30, 2021 | 293.84M |
| June 30, 2021 | 285.19M |
| March 31, 2021 | 255.30M |
| December 31, 2020 | 232.36M |
| September 30, 2020 | 231.32M |
| June 30, 2020 | 209.58M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Gilead Sciences, Inc. | 5.943B |
| Ionis Pharmaceuticals, Inc. | 923.08M |
| Johnson & Johnson | 16.02B |
| Arbutus Biopharma Corp. | 17.80M |
| Capricor Therapeutics, Inc. | 98.66M |